ARQT — Arcutis Biotherapeutics Inc · rev $235.3M

Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.

Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.

Use this ARQT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ARQT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ARQT SEC filings page. Lician reads the product cache first so this HTML stays unique to Arcutis Biotherapeutics Inc even when a live quote feed is slow.

Arcutis Biotherapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full ARQT income, balance, and cash tables.

  • Revenue$376.1M
  • Net Income-$16.1M
  • Total Assets$433.0M
  • Total Debt$0
  • Free Cash Flow-$6.3M

ARQT recent filings